Nicotine and Tobacco Message Framing Among LGBT Young Adults

Sponsor
Ohio State University Comprehensive Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05972941
Collaborator
National Institutes of Health (NIH) (NIH), National Cancer Institute (NCI) (NIH)
200
1
2
2.4
83.4

Study Details

Study Description

Brief Summary

This trial refines and evaluates how cultural targeting influences the effectiveness of anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine how cultural targeting can be applied to communicate polytobacco use risk to at-risk LGBT young adults.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health communications
N/A

Detailed Description

The goal of this study is to identify if culturally targeted (CT) or non-targeted (NT) anti-polytobacco messages are most effective for engaging LGBT consumers. Using the most effective NT messages from Aim 1, investigators will create a set of CT messages. Message framing will remain consistent between CT and NT messages; however, CT messages will include language and graphics representing LGBT values formative research and the existing peer-reviewed literature. Participants will be randomized to view CT or NT messages in a virtual lab where investigators will assess eye-tracking, self-reported perceived effectiveness, risk perceptions, and behavioral intentions. Participants will also complete a 1-week follow-up. The study aims to determine the effects of cultural targeting on attention to anti-polytobacco messages and perceived effectiveness among LGBT young adults susceptible to polytobacco use.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
The Effect of Nicotine and Tobacco Message Framing on Use Among Diverse Groups of Young Adults
Actual Study Start Date :
Jun 19, 2023
Anticipated Primary Completion Date :
Aug 31, 2023
Anticipated Study Completion Date :
Aug 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Culturally targeted messages

Participants will view 8 nicotine and tobacco health messages with LGBT culturally targeted messages and imagery

Behavioral: Health communications
Participants will view eight culturally targeted or non-targeted health communications about the health risks of nicotine and tobacco use.

Other: Non-targeted messages

Participants will view 8 nicotine and tobacco health messages with universal messages and imagery

Behavioral: Health communications
Participants will view eight culturally targeted or non-targeted health communications about the health risks of nicotine and tobacco use.

Outcome Measures

Primary Outcome Measures

  1. Visual attention - dwell time [During intervention]

    Visual attention measured by dwell time (milliseconds) on areas of interest (text, graphic) measured via eye-tracking

  2. Visual attention - time to first fixation [During intervention]

    Time (milliseconds) to first fixation on areas of interest (text, graphic) measured via eye-tracking

  3. Perceived message effectiveness - message perceptions [Immediately post-exposure to intervention]

    6-items on a 5-point scale where 1 = Not at all and 5 = Very much. Please rate each statement from 1 (not at all) to 5 (very much). These message are worth remembering. These messages grabbed my attention. These messages are powerful. These messages are convincing. These messages are meaningful. These messages are informative.

  4. Perceived message effectiveness - effects perceptions [Immediately post-exposure to intervention]

    6-items. 5-point scale where 1 = Strongly disagree to 5 = Strongly agree These messages discourage me from smoking cigarettes. These messages make me concerned about the negative effects of smoking cigarettes These messages make smoking cigarettes seem unpleasant to me. These messages discourage me from vaping nicotine. These messages make me concerned about the negative effects of vaping nicotine. These messages make vaping nicotine seem unpleasant to me.

  5. Change in harm perceptions [Change from Baseline in harm perceptions immediately post-exposure to intervention]

    3-items; 4-point scale 1=No harm to 4 = A lot of harm How harmful are nicotine vapes to your health? Compared to combustible cigarettes, how harmful are nicotine vapes to your health? How harmful are combustible cigarettes to your health?

  6. Change in harm perceptions [Change from Baseline in harm perceptions at 1-week follow-up after intervention exposure]

    3-items; 4-point scale 1=No harm to 4 = A lot of harm How harmful are nicotine vapes to your health? Compared to combustible cigarettes, how harmful are nicotine vapes to your health? How harmful are combustible cigarettes to your health?

  7. Change in behavioral intentions [Change from Baseline in behavioral intentions immediately post-exposure to intervention]

    8 items total. 4-point scale 1 = Definitely not to 4 = Definitely will. How likely is it that in the next 3 months, you will refrain from vaping nicotine.... completely and permanently? when you get lonely? when you are with your friends who use them? when someone hands you a vape? How likely is it that in the next 3 months, you will refrain from smoking cigarettes... completely and permanently? when you get lonely? when you are with your friends who use them? when someone hands you a vape?

  8. Change in behavioral intentions [Change from Baseline in behavioral intentions at 1-week follow-up after intervention exposure]

    Do you plan to quit smoking cigarettes in the next 30 days (Yes/No) Do you plan to quit vaping in the next 30 days (Yes/No)

Secondary Outcome Measures

  1. Reactance [Immediately post-exposure to intervention]

    3-items; 5-point Likert scale where 1 = Strongly disagree and 5 = Strongly agree These messages are trying to manipulate me. These messages annoy me. The health effects of these messages are overblown.

  2. Ad relevance [Immediately post-exposure to intervention]

    5 items; 7-point Likert scale where 1 = Strongly Disagree and 7 = Strongly agree These ads were created just for me. These ads were created for people like me. These ads were relevant to me. These ads were of value to me. These ads were important to me.

  3. Liking [Immediately post-exposure to intervention]

    Single item; 5-point Likert scale where 1 = Strongly disagree and 5 = Strongly agree I like these messages.

  4. Attitudes [Immediately post-exposure to intervention]

    Two items; 7-point Likert scale where 1 = These message made me feel much worse and 7 = These message made me feel much better. Did these messages change how you feel about smoking combustible cigarettes? Did these messages change how you feel about vaping nicotine?

  5. Response efficacy [Immediately post-exposure to intervention]

    6-items; 5 point Likert scale where 1 = Strongly disagree and 5 = Strongly agree These messages will motivate CIGARETTE SMOKERS to switch to vaping. These messages will motivate people to quit ALL smoking and vaping. These messages will motivate NON-USERS to start vaping. These messages will motivate NON-USERS to start smoking cigarettes. These messages will motivate CIGARETTE SMOKERS to quit. These messages will motivate VAPERS to quit.

  6. Qualitative recall of health messages [1-week follow-up after intervention exposure]

    Participants will be asked the following question: "The images that you viewed included health messages. What do you remember about the health messages?"

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Speaks English fluently

  • Self-identifies as lesbian, gay, bisexual, transgender, queer, or another non- heterosexual orientation or non-binary gender identity

  • Ever used e-cigarettes AND combustible cigarettes

  • Currently uses e-cigarettes, combustible cigarettes, or both e-cigarettes and combustible cigarettes

  • Resides in the United States

  • Access to a laptop or desktop computer with a camera for virtual eye-tracking

Exclusion Criteria:
  • Glaucoma

  • Cataracts

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University Comprehensive Cancer Center
  • National Institutes of Health (NIH)
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Joanne G Patterson, PhD, The Ohio State University College of Public Health

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Joanne Patterson, Principal Investigator, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT05972941
Other Study ID Numbers:
  • OSU-23020
  • 4R00CA260718-02
First Posted:
Aug 2, 2023
Last Update Posted:
Aug 2, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joanne Patterson, Principal Investigator, Ohio State University Comprehensive Cancer Center

Study Results

No Results Posted as of Aug 2, 2023